Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Reckitt (DE:3RB)
XETRA:3RB
Holding DE:3RB?
Track your performance easily
3RB Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€47.52 - €69.00
Previous Close€58.48
Volume6.04K
Average Volume (3M)10.47K
Market Cap
€40.12B
Enterprise Value€48.72B
Total Cash (Recent Filing)£1.39B
Total Debt (Recent Filing)£8.54B
Price to Earnings (P/E)23.1
Beta0.45
Next Earnings
Mar 06, 2025EPS Estimate
€1.85Last Dividend Ex-Date
Aug 01, 2024Dividend Yield4.05%
Share Statistics
EPS (TTM)2.54
Shares Outstanding692,672,417
10 Day Avg. Volume6,234
30 Day Avg. Volume10,473
Standard Deviation0.06
R-Squared0.07
Alpha-0.00002
Financial Highlights & Ratios
Price to Book (P/B)4.90
Price to Sales (P/S)2.30
Price to Cash Flow (P/CF)16.80
P/FCF Ratio17.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€62.52Price Target Upside6.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Reckitt News
PremiumCompany Announcements
Reckitt’s Share Buyback Signals Confidence in Financial Health
PremiumCompany Announcements
Reckitt Benckiser Strengthens Board with New Directors
PremiumCompany Announcements
Reckitt Benckiser Strengthens Position with Share Buyback
PremiumCompany Announcements
Reckitt Benckiser Announces Share Repurchase UpdatePremiumCompany Announcements
Reckitt Benckiser Enhances Capital Structure with Share BuybackPremiumCompany Announcements
Reckitt Benckiser Buys Back Shares to Boost CapitalBulls Say, Bears Say
Bulls Say
Financial Performance3Q sales growth is better than expected, with the key driver being a beat in Nutrition, as the feared disruption from a warehouse outage proved to be less significant.
Legal OutcomeA jury found in favour of Mead Johnson and its co-defendant, Abbott, which could lessen concerns on final settlement liabilities.
Market PerformanceThe company's market share in Health & Hygiene divisions improved markedly, moving from approximately 43% to around 60% of sales holding or gaining share.
Bears Say
Financial PerformanceQ3 seen as unlikely to support share price with late retailers’ reordering in flu and signs of pricing deterioration in Hygiene.
Growth And Market ShareLack of competitiveness and spending to extend reach still weigh on sales.
Litigation RiskUncertainties persist on both litigation & logic of strategic plans.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.02% Insiders
15.25% Mutual Funds
<0.01% Other Institutional Investors
73.43% Public Companies and
Individual Investors
3RB FAQ
What was Reckitt’s price range in the past 12 months?
Reckitt lowest stock price was €47.52 and its highest was €69.00 in the past 12 months.
What is Reckitt’s market cap?
Currently, no data Available
When is Reckitt’s upcoming earnings report date?
Reckitt’s upcoming earnings report date is Mar 06, 2025 which is in 99 days.
How were Reckitt’s earnings last quarter?
Reckitt released its earnings results on Jul 24, 2024. The company reported €1.929 earnings per share for the quarter, beating the consensus estimate of €1.866 by €0.064.
Is Reckitt overvalued?
According to Wall Street analysts Reckitt’s price is currently Undervalued.
Does Reckitt pay dividends?
Reckitt pays a Annually dividend of €0.94 which represents an annual dividend yield of 4.05%. See more information on Reckitt dividends here
What is Reckitt’s EPS estimate?
Reckitt’s EPS estimate is €1.85.
How many shares outstanding does Reckitt have?
Reckitt has 688,190,300 shares outstanding.
What happened to Reckitt’s price movement after its last earnings report?
Reckitt reported an EPS of €1.929 in its last earnings report, beating expectations of €1.866. Following the earnings report the stock price went up 2.058%.
Which hedge fund is a major shareholder of Reckitt?
Currently, no hedge funds are holding shares in DE:3RB
---
Reckitt Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€62.52 (6.44% Upside)
€62.52 (6.44% Upside)
Blogger Sentiment
Bullish
DE:3RB Sentiment 100%
Sector Average 65%
Sector Average 65%
Insider Transactions
Sold Shares
Worth £837.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.98%
12-Months-Change
Fundamentals
Return on Equity
17.90%
Trailing 12-Months
Asset Growth
-4.02%
Trailing 12-Months
Company Description
Reckitt
European firms Reckitt & Coleman and Benckiser combined in 1999 to form Reckitt Benckiser, which recently rebranded to the corporate name RB. The firm's products include a variety of household and personal-care brands, such as Calgon, Lysol, Finish, and Mucinex, many of which have the number-one or -two position in their categories. More recently, RB has repositioned its portfolio, and has entered infant formula through the acquisition of Mead Johnson, expanded its consumer health presence by acquiring SSL International, Schiff Nutrition, and K-Y, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 40% of sales from emerging markets.
---
3RB Stock 12 Month Forecast
Average Price Target
€62.52
▲(6.44% Upside)
Technical Analysis
Best Analysts Covering 3RB
1 Year
1 Year Success Rate
23/37 ratings generated profit
1 Year Average Return
+1.86%
reiterated a buy rating 23 days ago
Copying Iain Simpson's trades and holding each position for 1 Year would result in 62.16% of your transactions generating a profit, with an average return of +1.86% per trade.
---